Researchers studied the link between cardiovascular-kidney-metabolic syndrome (CKM syndrome) and risk of cancer. CKM syndrome refers to several connected health conditions, including heart disease, ...

Sometimes we give chemotherapy after surgery or radiation. The idea there is that surgery or radiation can remove any visible signs of disease, but there could be microscopic cells still floating ...

Breaking a 15-year silence on his skin cancer diagnosis, Jerry Jones says he took an experimental checkpoint inhibitor, a type of immunotherapy.

A new study highlights the scale and scope of the Trump administration’s termination of National Cancer Institute (NCI) research grants since it slashed cancer research funding in early 2025 and cut ...

Rising rates of colorectal cancer, especially among young people, have researchers seeking to identify ways to increase cancer screening. Three new studies published in JAMA Network and JAMA Oncology ...

McLeod is one of nearly 19 million U.S. cancer survivors, many of whom continue to need prescriptions, doctor visits, and procedures to monitor their condition and manage posttreatment side effects.

But in fact, research on personalized cancer vaccines, designed to help the immune system recognize and attack tumors, has been underway for at least a decade. Scientists have reported promising ...

The latest study, titled “A global perspective on coal-fired power plants and burden of lung cancer,” published in the journal Environmental Health, looked at data from 13,581 coal-fired plants in 83 ...

In 2009, Melinda Bachini was working as a paramedic when she was diagnosed with cholangiocarcinoma, a rare cancer of the bile ducts, which soon spread to her lungs. Two years later, she decided that ...

In 1996, former professional road racing cyclist and seven-time Tour de France winner Lance Armstrong, who became a disgraced champion for using performance-enhancing drugs, was diagnosed with ...

On September 19, the Food and Drug Administration (FDA) approved Keytruda Qlex, an injectable formulation of the widely used immune checkpoint inhibitor pembrolizumab. The European Medicines Agency ...

“The latest data from the Phase I trial are encouraging,” lead investigator Vinod Balachandran, MD, of Memorial Sloan Kettering Cancer Center, said in a news release. “They suggest this ...